SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-001842
Filing Date
2024-05-28
Accepted
2024-05-28 07:11:36
Documents
6
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 6-K zk2431511.htm 6-K 9490
2 REGISTRANT'S PRESS RELEASE DATED MAY 28, 2024 exhibit_1.htm EX-99.1 301804
3 REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, exhibit_2.htm EX-99.2 353572
4 REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF MARCH 31, 2024 AND FOR THE THR exhibit_3.htm EX-99.3 191146
5 image00001.jpg GRAPHIC 236871
6 image00003.jpg GRAPHIC 2824
  Complete submission text file 0001178913-24-001842.txt   1187477
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 24986258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)